Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody

Rui Pei1, Jar-How Lee, Neng-Jen Shih

  • 1Research Department, One Lambda. Inc., Canoga Park, CA, USA. rpei@onelambda.com

Transplantation
|January 25, 2003
PubMed

Insights

A new single human leukocyte antigen (HLA) bead panel improves antibody identification for highly sensitized patients. This flow cytometry method offers greater accuracy and sensitivity in detecting HLA antibodies, aiding transplant readiness.

Area of Science:

  • Immunology
  • Transplantation Science
  • Biotechnology

Background:

  • Assigning antibody specificity in highly sensitized patients is challenging with conventional multi-antigen cell panels.
  • Accurate human leukocyte antigen (HLA) antibody identification is crucial for successful organ transplantation and transfusion management.

Purpose of the Study:

  • To develop and validate a single antigen bead panel for precise identification of HLA antibody specificities.
  • To enhance the accuracy and sensitivity of HLA antibody detection in flow cytometry.

Main Methods:

  • Produced 110 single recombinant human leukocyte antigens (HLAs) across A, B, and C loci using a mammalian expression system.
  • Coated single HLAs onto distinct colored microbeads for simultaneous detection of antibodies against eight antigens per test.
  • Utilized flow cytometry for simultaneous detection of HLA antibodies.

Main Results:

  • Single HLA beads demonstrated specific reactions with monoclonal antibodies, offering higher resolution than traditional cell panels.
  • The single antigen approach uncovered masked specificities and showed increased sensitivity in serum dilution studies.
  • In kidney transplant rejection patients, single antigen beads identified antibodies to mismatched donor antigens with high accuracy.

Conclusions:

  • A novel, accurate, and sensitive method for HLA antibody detection using recombinant single HLA-coated flow cytometry beads has been established.
  • This single antigen bead technology is valuable for predicting negative crossmatches in highly sensitized organ transplant recipients and patients needing platelets.
Abstract

Related Concept Videos